PBH +18.21%: a strong day for the wagering business with the double benefit of corporate interest and a positive broker note. Broker Goldman Sachs revised their earnings forecasts marginally lower but talked up PointsBet’s outlook including their ability to carve out a portion of the growing US market and increasing long term margins and scale while noting promotional intensity had eased. CNBC were also reporting that PointsBet were in discussions with Yahoo Sports who are looking at merger opportunities with a wagering business.
scroll
Question asked
Question asked
Question asked
Question asked
Question asked
Question asked
Question asked
Question asked
Question asked
Question asked
Performance update for March, stocks that drove returns & our current positioning
Close
Thursday 18th April – ASX200 +32pts, Resmed (RMD), Transurban (TCL), Santos (STO) & SRG Global (SRG)
Close
Market Matters Research Lead Shawn Hickman with David Koch
Close
Thursday 18th April – DOW -45pts, SPI +20pts
Close
MM is long PBH in the Emerging Companies Portfolio
Add To Hit List
Related Q&A
Why would MM sell DUB/PBH?
What’s MM’s longer term view towards PBH?
MM’s thoughts on PBH & DUB
MM’s view on PointsBet (PBH) & a2 Milk (A2M)
Thoughts on Aristocrat (ALL) and PointsBet (PBH)
Thoughts on Pointsbet & Nitro?
Do you think the current dip a good opportunity to add or build positions?
Codan (CDA) & PointsBet (PBH) – whats going on?
What stocks would we top up here?
Is PointsBet (PBH) worth a punt?
Relevant suggested news and content from the site
Video
WATCH
Performance update for March, stocks that drove returns & our current positioning
Recorded Tuesday 9th April
Podcast
LISTEN
Thursday 18th April – ASX200 +32pts, Resmed (RMD), Transurban (TCL), Santos (STO) & SRG Global (SRG)
Daily Podcast Direct from the Desk
Video
WATCH
Market Matters Research Lead Shawn Hickman with David Koch
Recorded Monday 25th March
Podcast
LISTEN
Thursday 18th April – DOW -45pts, SPI +20pts
Daily Podcast Direct from the Desk
Members only
UNLOCK MARKET MATTERS NOW
Take a free trial.
No payment details required.